Musings About Factor Exposure Analysis


Visit: Smartkarma

By: FactorResearch


  • There are few alternatives to regression analysis when explaining investment performance
  • Too few as well as too many independent variables can be problematic
  • The results are often not intuitive, but also encourage asking further questions that may prove insightful


The older I become, the less I feel I know anything with certainty. Almost every aspect of life seems to have various degrees of grey rather than being black and white. Most knowledge seems to peel away like an onion at closer inspection and highlights different shades, but rarely an ultimate truth.

For example, eating sushi for lunch feels better from a nutritional and calorie perspective compared to eating a cheeseburger or a pizza. However, tuna tends to contain heavy metals and salmon nasty pesticides that are both likely detrimental to our health. So, is eating sushi good or bad for our health? Or should we prefer the cheeseburger? Tough to say.

Similar questions arise when analyzing the performance of investment portfolios. Even simple portfolios, e.g. a traditional one comprised of equities (60%) and bonds (40%), can be dazzling complex when inspected closely. Isn’t the equity allocation responsible for most of the portfolio risk? Which asset class contributed most of the returns? And are those explained by plain beta or a tilt to certain factors?

The classic approach to answering such portfolio analysis questions is by conducting a contribution analysis via factor exposures. However, this often raises more questions than it provides answers to.

In this short research note, we will explore some of the challenging aspects of regression-based factor exposure analysis.


We will explore factor exposure analysis by primarily focusing on six simple portfolios comprising US large-cap stocks (S&P 500), US small caps, US low-risk stocks, international as well as emerging market (EM) stocks, and a multi-asset portfolio.

Comparing the performance of the six portfolios in the period between 2015 and 2020 highlights similar trends. The S&P 500 generated the highest returns, but it depends on the lookback period, e.g. EM stocks outperformed in the first two years. It is interesting to note that even the multi-asset portfolio exhibited the same performance characteristics, which indicates a significant allocation to equities.

Performance of the Portfolios

Source: FactorResearch


First, we conduct a simple regression-based factor exposure analysis using only two indices, which are a market capitalization-weighted index for global stocks and a composite bond index that is comprised of US government, corporate, and high yield fixed income securities. 

We observe that the R2 was high for US large caps, international stocks, and the multi-asset portfolio, but slightly lower for the other portfolios. Given that five out of the six portfolios are exclusively comprised of stocks, it is not surprising to see a high positive exposure to the global equity index.

Somewhat more unusual is the negative bond exposure of small caps and positive exposure of low-risk and EM stocks. Intuitively, equity portfolios should not have exposure to fixed income. If there was positive exposure, then this would imply reduced diversification benefits when combining stocks and bonds. Thus, negative exposure means additional exposure to similar drivers as those of equity exposure.

Simple Factor Exposure Analysis: R2 & Factor Betas

Source: FactorResearch


Next, we separate the global equity index into US, international, and emerging markets and the composite bond index by the type of fixed income instrument. Rerunning the factor exposure analysis with more independent variables seems to result in factor exposures that are more precise, e.g. the equity exposure of emerging market stocks is allocated to the emerging markets equity index. 

The aggregate bond exposure reduces for all of the portfolios, except for the low-risk stock portfolio and the multi-asset portfolio. The exposure of the former might be explained by low-risk stocks often coming from sectors like real estate or utilities that are interest-rate sensitive due to high corporate leverage. In the latter case, this simply indicates that the multi-asset portfolio contains bonds.

Detailed Factor Exposure Analysis: R2 & Factor Betas

Source: FactorResearch


Finally, we add five additional equity factors to the regression analysis. Specifically, we include factors that have been identified by academic researchers to explain almost all the out- and underperformance of active managers, namely value, size momentum, low volatility, and quality.

The inclusion of these additional independent variables leads to further changes in the factor betas. We observe that the small-cap portfolio shows a large positive exposure to the Size factor. The bond exposure of low-risk stocks decreased while the exposure to the Low Volatility factor increased. 

Detailed Factor Exposure Analysis with Equity Factors: R2 & Factor Betas

Source: FactorResearch


We can contrast the changes in the regression analysis by comparing the R2 of the results, which increased consistently when the number of independent variables was increased. However, more variables are not necessarily better as it is difficult to find variables that are independent and also have a sound theoretical foundation for inclusion. 

The more independent variables, the higher the probability that the analysis is subject to multicollinearity. For example, the correlation between US, international, emerging stocks, and high yield bonds is relatively high as these provide similar risk exposure. This can partially be addressed by residualizing the variables or changing the type of regression, e.g. by using a Lasso instead of a simple linear regression.

Furthermore, index construction matters. Many factor indices in the public domain are constructed dollar- and not beta-neutral, which implies that the factors have implicit positive or negative beta exposure. Naturally, this distorts the results of the factor exposure analysis as equity indices represent the market beta.

R2 by Number of Independent Variables

Source: FactorResearch


So far we analyzed portfolios that were relatively simple and where returns could clearly be attributed to well-known sources of returns. However, often even stock-based portfolios make contribution analysis challenging. 

In order to highlight this, we create three additional portfolios that have more unique characteristics. One portfolio comprises companies that generate almost all revenues in the US while the other two are focused solely on international markets and are differentiated between US and foreign-headquartered firms that have listed their stocks on US exchanges via ADRs, e.g. Alibaba. 

Conducting a detailed factor exposure analysis highlights that the returns are primarily explained by the US stock market and the Size factor, which seems reasonable given that the stocks are traded in the US and have small market capitalizations on average. However, it is interesting to note that the portfolio of companies conducting almost all their business outside of the US has almost zero exposure to international stocks markets. Why is there no positive exposure? 

Furthermore, there is also positive exposure to US government bonds. Why? Given that these portfolios are comprised of risky equities, it is difficult to fathom why these stocks should behave like safe US treasuries.

Unfortunately, there are often no obvious answers for explaining some of the unusual results of factor exposure analysis. However, it is worth paying attention to the R2 and p-values as these indicate that in many cases that the model overall is not good at explaining the returns, like for the ADR-based portfolio, or that some of the individual factor betas are statistically not significant and can therefore be ignored.

Unusual Equity Portfolios: Detailed Factor Exposure Analysis with Equity Factors

Source: FactorResearch


The earliest form of linear regression calculations were conducted more than 200 years ago by the French and German mathematicians Legendre and Gauss, in 1805 and 1809 respectively. There have been some advancements in the methodology since then, but these were rather evolutionary than revolutionary. 

The exponential increase in data and better computing power have led to significant learnings in the machine learning space, where many concepts are based on regression analysis. However, none of these newer methodologies seems to be a better alternative to plain vanilla regression analysis for analyzing the returns of investment portfolios.

The methodology has plenty of flaws and often results in output that is not intuitive. However, it also leads to asking additional questions and conducting further analysis, which often results in a better understanding of what has been driving the portfolio performance. 

Originally Posted Jan 11, 2021 – Musings About Factor Exposure Analysis

Disclosure: Smartkarma

Smartkarma posts and insights are provided for informational purposes only and shall not be construed as or relied upon in any circumstances as professional, targeted financial or investment advice or be considered to form part of any offer for sale, subscription, solicitation or invitation to buy or subscribe for any securities or financial products. Views expressed in third-party articles are those of the authors and do not necessarily represent the views or opinion of Smartkarma.

Disclosure: Interactive Brokers

Information posted on IBKR Traders’ Insight that is provided by third-parties and not by Interactive Brokers does NOT constitute a recommendation by Interactive Brokers that you should contract for the services of that third party. Third-party participants who contribute to IBKR Traders’ Insight are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from Smartkarma and is being posted with permission from Smartkarma. The views expressed in this material are solely those of the author and/or Smartkarma and IBKR is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

In accordance with EU regulation: The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.

Any trading symbols displayed are for illustrative purposes only and are not intended to portray recommendations.